Our final results indicate that tolvaptan would not noticeably have an effect on HRQoL in patients with ADPKD who tolerate treatment over and above the main 3 months of therapy.You have requested "on-the-fly" device translation of picked content material from our databases. This functionality is presented entirely to your comfort and is on no accou